AVR 0.00% $18.00 anteris technologies ltd

Ann: Admedus to showcase CardioCel at EACTS Annual Meeting, page-4

  1. 8,392 Posts.
    lightbulb Created with Sketch. 257
    ASX ANNOUNCEMENT

    ADMEDUS TO SHOWCASE CARDIOCEL® AT EUROPEAN ASSOCIATION FOR CARDIO-THORACIC SURGERY (EACTS) ANNUAL MEETING

     Key Sponsor of Techno-College, 11th October, 2014
     Exhibiting at booth #123, 12th - 14th October, 2014
     Admedus hosting CardioCel® Satellite Symposium, 13th October, 2014
    Brisbane, Australia, 10th October, 2014

    Admedus Limited (ASX:AHZ) announced today its attendance at the European
    Association for Cardio-Thoracic Surgery (EACTS) 28th Annual Meeting to be held in
    Milan from the 11th -15th October, 2014.

    Admedus will be showcasing CardioCel®, its advanced cardiovascular scaffold currently
    marketed in Europe and the US, at its booth and at a number of presentations and
    symposia. Following CE marking and FDA 510k clearance, CardioCel® is seeing
    increasing adoption as the tissue of choice for the repair of congenital heart
    deformities, more complex heart defects and heart valve repair procedures.
    CardioCel® clinical data will feature on Saturday, 11th October at the Admedus
    sponsored Techno-College, where Admedus will also have an exhibition booth. The
    Annual Techno-College is an integral part of EACTS and provides an update on the
    latest developments in the field of cardiovascular, thoracic and congenital surgery.
    Admedus will be exhibiting at booth #123 in the main hall from Sunday evening until
    Tuesday evening. A wet lab will be set up in the booth for hands-on CardioCel®
    product demonstrations.

    The CardioCel® Satellite Symposium will take place from 12:45 – 14:00 on Monday,
    13th October at the Milano Congressi in room Amber 6. Chaired by Prof. Mark
    Hazekamp, LUMC, The Netherlands, the symposium will comprise surgeon
    presentations and an open forum on the CardioCel® scaffold tissue engineering
    process and clinical usage to date. Panellists include:
     Prof. William Neethling, University of Western Australia;
     Prof. Tom Karl, Mater Children’s Hospital, Brisbane;
     Mr Olivier Ghez, Royal Brompton Hospital,

    real good imo
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
(20min delay)
Last
$18.00
Change
0.000(0.00%)
Mkt cap ! $346.0M
Open High Low Value Volume
$18.00 $18.10 $17.70 $58.64K 3.27K

Buyers (Bids)

No. Vol. Price($)
1 109 $18.00
 

Sellers (Offers)

Price($) Vol. No.
$18.10 700 1
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
AVR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.